Notably, treatment with Hrnr siRNA and AV-951 (combo) resulted in a 4.3-fold decrease in volume compared to the control group, indicating that inhibition of VEGF combined with hornerin knockdown results in an additive reduction in tumor growth (Fig. 6c). This evidence concerns the gene HRNR and neoplasm.